Medical Devices Startups

Human Med develops and manufactures medical devices for water-jet assisted liposuction (WAL) using its AquaShape method, aimed at gentle fat removal and autologous fat transfer. Its products serve medical professionals in aesthetic, reconstructive, and regenerative plastic surgery.

1 investor

Human Xtensions develops HandX, a handheld surgical device with detachable single-use instruments intended to bridge the gap between laparoscopic and robotic surgery. Its technology is used across procedures in general surgery, gynecology, and urology, and it offers a mentoring program (XSmart) and a clinical library for surgeons.

1 investor

Humanaut provides regenerative medicine, sexual health, and advanced therapies through clinician-led care that emphasizes transparency and patient empowerment. The company serves individuals seeking precision medicine with ethical pricing and a focus on long-term wellness outcomes.

1 investor

Humasis develops and manufactures in-vitro diagnostic medical devices, producing 163 product items through its central R&D lab focused on diagnostic source technologies. Founded in 2000, the South Korean company exports its diagnostic products to 74 countries.

1 investor

Humedics develops LiMAx, a breath analysis technology for rapid and precise measurement of liver function, enabling doctors to make tailored treatment decisions at the bedside. The company serves healthcare providers and hospitals in diagnostic medicine.

1 investor

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

Husky manufactures injection molding systems designed to optimize productivity and consistency across industries including beverage packaging, medical devices, food containers, and diagnostics. The company offers a comprehensive portfolio of specialized molding platforms for high-volume and mid-volume production applications.

1 investor

HVR Cardio develops medical devices for cardiovascular applications, drawing on a management team with combined expertise in structural heart technologies and medical device commercialization.

1 investor

Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.

1 investor

Fantex is a hard surface cleaner formulated to kill up to 99.999% of germs and pathogens within one minute, with residual protection lasting up to 24 hours, suitable for use on all hard surfaces including food preparation areas. The product is tested against international standards and proven effective against bacteria, fungi, and viruses including MRSA, norovirus, and coronavirus.

1 investor

HyliDx develops a home-based blood testing and remote care platform for monitoring chronic kidney disease and heart failure, delivering lab-accurate results in 5 minutes from a finger-prick sample with integrated cloud AI analysis for complications prediction. The platform targets patients with advanced CKD, dialysis patients, and high-risk cardio-renal populations across North America and Europe to reduce hospitalizations and healthcare costs.

1 investor

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults. The company partners with foundations to deploy the technology for neuroimaging in conditions such as hydrocephalus and early brain development monitoring in low- and middle-income countries.

1 investor

Hyris provides diagnostic testing solutions and marketplace technology for healthcare facilities and agricultural operations, enabling distributed testing networks managed from a central hub and pathogen detection services.

1 investor

Hangzhou Bangier Orthopedic Hospital (Hangzhou Linping Orthopedic Hospital), established in 2006, is a national health-insurance-designated orthopedic specialty hospital that emphasizes conservative and minimally invasive treatment. It operates six specialized orthopedic centers covering spine, joint and sports medicine, trauma, hand and foot repair, and pediatric bone development, serving patients in the Linping district of Hangzhou, China.

1 investor

Ikonopedia provides a breast imaging software platform for radiologists and patients, featuring structured reporting tools, risk assessment, and closed-loop lesion tracking to ensure comprehensive breast health management and follow-up care.

1 investor

i-PRO develops and manufactures camera modules and image processing boards for medical devices such as surgical microscopes and endoscopes, selling to medical device manufacturers. The company leverages spectroscopic and pixel shift precision bonding technologies to deliver high-definition visualization for surgical and diagnostic applications.

1 investor

i3 develops a hybrid intravascular imaging catheter combining near-infrared fluorescence (NIRF) and ultrasound (IVUS) sensors to provide real-time molecular and structural imaging during coronary interventions. The system enables detection of arterial injury and complications in cardiac catheterization procedures.

1 investor

Fluidics designs and manufactures customized microparticles and capsules for businesses requiring specialized formulations, leveraging in-house capabilities for active protection, controlled release, and formulation enhancement.

1 investor

Iaso Automated Medical Systems is a medical device company developing machine learning-based technology to detect and manage Acute Respiratory Distress Syndrome (ARDS) in intensive care units. The company helps critical care teams make evidence-based decisions through early warning systems and clinical decision support for critically-ill patients.

1 investor

IBI SA (Industrie Biomediche Insubri SA) researches, develops, and produces medical devices for tissue engineering and regenerative medicine, including bone substitutes, grafts, 3D matrixes, and 2D scaffolds.

1 investor

iCAD develops FDA-cleared, AI-based solutions for breast cancer detection, breast density assessment, and risk evaluation, used by radiologists in mammography workflows. Its offerings support 2D and 3D digital breast tomosynthesis screening to aid earlier cancer detection.

1 investor

ICBII develops molecular technology platforms designed to deliver therapeutic molecules across the blood-brain barrier to treat neurodegenerative diseases such as Parkinson's and Alzheimer's. The company focuses on advancing drug delivery capabilities for treating major diseases affecting the central nervous system.

1 investor

Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.

1 investor

Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.

1 investor